Apelin-36 (rat, mouse)
Cat. No. 2427
Biological ActivityEndogenous APJ receptor agonist that is secreted by adipocytes. Binds with high affinity to APJ receptors (IC50 = 5.4 nM) and potently inhibits cAMP production in vitro (EC50 = 0.52 nM). Involved in regulation of cardiovascular function, fluid homeostasis and feeding. Blocks entry of some HIV-1 and HIV-2 strains into NP-2/CD4 cells expressing APJ.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Tatemoto et al (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem.Biophys.Res.Comm. 251 471.
Zou et al (2000) Apelin peptides block the entry of human immunodeficiency virus (HIV). FEBS Lett. 473 15. PMID: 10802050.
Kawamata et al (2001) Molecular properties of apelin: tissue distribution and receptor binding. Biochim.Biophys.Acta 1538 162. PMID: 11336787.
If you know of a relevant citation for this product please let us know.
Keywords: Apelin-36 (rat, mouse), supplier, Endogenous, APJ, receptors, agonists, Apelin, adipokines
Find multiple products by catalog number
New Products in this Area
Selective motilin receptor antagonistAdipoRon hydrochloride
Orally active AdipoR1 and AdipoR2 agonist; antidiabeticPG 931
Potent and selective MC4 receptor agonistCYM 50769
Novel non-peptide NPBWR1 antagonistPramlintide
Synthetic version of amylin (Cat. No. 3418)
June 30 - July 2, 2014
Booth Number: 39